It is the third most common cancer in UK women, and there are ways to check for signs.
Better than that, you can self-test for it at home. Studies have found that 78% of us are more comfortable with home testing after using lateral flow tests. You can buy at home diagnostic tests for bowel cancer – and a range of other health conditions – from Tesco stores all over the UK.
And it's certainly worth the investment. Sadly, 42,900 new cases of bowel cancer are recorded in the UK annually and the disease is the third most common cancer found in UK women. Early diagnosis can also help save lives and knowing what to look out for can be the key to getting the help you need.final plea was for us all to “check our poo", a hashtag she often used on social media, as well as a topic she spoke about widely in interviews.
She died from bowel cancer on 28 June 2022, five years after she was first diagnosed. Before her passing, the campaigner set up the legacy foundation,, which, at the time of writing, has now raised more than £6.9million for charities such as Cancer Research UK, Bowel Cancer UK, and Royal Marsden Cancer Charity.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Global colorectal cancer (CRC) awareness report 2023 reveals cost concerns while disease history doubles family's screening rateRecognizing the concerns of CRC, BGI Genomics has launched the first-ever global colorectal cancer awareness report, to better understand the global state of CRC awareness.
Lire la suite »
Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer - Cardio-OncologyBackground Though the incidence of atrial fibrillation (AF) is increased in patients with cancer, the effectiveness of catheter ablation (CA) for AF in patients with cancer is not well studied. Methods We conducted a retrospective cohort study of patients who underwent CA for AF. Patients with a history of cancer within 5-years prior to, or those with an exposure to anthracyclines and/or thoracic radiation at any time prior to the index ablation were compared to patients without a history of cancer who underwent AF ablation. The primary outcome was freedom from AF [with or without anti-arrhythmic drugs (AADs), or need for repeat CA at 12-months post-ablation]. Secondary endpoints included freedom from AF at 12 months post-ablation with AADs and without AADs. Safety endpoints included bleeding, pulmonary vein stenosis, stroke, and cardiac tamponade. Multivariable regression analysis was performed to identify independent risk predictors of the primary outcome. Results Among 502 patients included in the study, 251 (50%) had a history of cancer. Freedom from AF at 12 months did not differ between patients with and without cancer (83.3% vs 72.5%, p 0.28). The need for repeat ablation was also similar between groups (20.7% vs 27.5%, p 0.29). Multivariable regression analysis did not identify a history of cancer or cancer-related therapy as independent predictors of recurrent AF after ablation. There was no difference in safety endpoints between groups. Conclusion CA is a safe and effective treatment for AF in patients with a history of cancer and those with exposure to potentially cardiotoxic therapy.
Lire la suite »
East Atlantic Flyway UNESCO nomination is 'tremendous news'RSPB Minsmere says the accolade, if awarded, will help 'raise awareness of the landscape scale'.
Lire la suite »
Family of Ayrshire tot battling cancer launch £250,000 plea for trial drugScott and Natalie Bolton are seeking help after their little girl Ava, 3, who was diagnosed with stage 4 high-risk neuroblastoma.
Lire la suite »
Family's heartbreak after mum dies of cancer just months after holiday tragedyGemma Pana's mum Sandra Navin, was told by doctors that she had terminal cancer in March last year, leaving her husband Graham and their four children heartbroken.
Lire la suite »
Unseen Unheard: The untold breast cancer storiesARTISTIC DIRECTOR of Theatre Peckham, Suzann McLean, says ensuring the south London venue is utilised to 'shed light on the experiences of underrepresented communities', is of paramount importance.
Lire la suite »